M&A Deal Summary |
|
---|---|
Date | 2016-11-21 |
Target | Solon Eiendom AS |
Sector | Real Estate |
Buyer(s) | Solon Eiendom |
Deal Type | Add-on Acquisition |
Deal Value | 1.0B NOK |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 1993 |
Sector | Life Science |
Employees | 49 |
Revenue | 1.5B NOK (2020) |
Solon Eiendom is a developer of vaccines for human immunodeficiency virus, Hepatitis C and Influenza. Solon Eiendom was founded in 1993 and is based in Oslo, Norway.
DEAL STATS | # |
---|---|
Overall | 1 of 1 |
Sector (Real Estate) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 1 |
Country (Norway) | 1 of 1 |
Year (2016) | 1 of 1 |
Size (of disclosed) | 1 of 1 |